Literature DB >> 10235597

Decreased dopamine receptor expression and its second-messenger cAMP in malignant human colon tissue.

S Basu1, P S Dasgupta.   

Abstract

As an important enteric neurotransmitter, the role of dopamine as a mitotic inhibitor as well as a protective factor of epithelial cells of stomach and colon indicates its significance in malignant growth of gastrointestinal tract. Our previous results have shown significant alteration of dopamine receptors in human malignant stomach tissues. The present experiments, therefore, evaluate DA content, its receptor expression, and its second-messenger cAMP in human malignant colon tissues to evaluate its role. Results demonstrate a significant decrease of dopamine content, its receptor expression, and its second-messenger cAMP in malignant tissues of human colon. These results may provide insight into the role of dopamine as an enteric neurotransmitter on malignant growth of human colon and may also suggest a therapeutic approach targeting dopamine receptors and its signal transduction.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10235597     DOI: 10.1023/a:1026644110737

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  24 in total

1.  Alteration of dopamine D2 receptors in human malignant stomach tissue.

Authors:  S Basu; P S Dasgupta
Journal:  Dig Dis Sci       Date:  1997-06       Impact factor: 3.199

Review 2.  Molecular diversity of the dopamine receptors.

Authors:  O Civelli; J R Bunzow; D K Grandy
Journal:  Annu Rev Pharmacol Toxicol       Date:  1993       Impact factor: 13.820

Review 3.  Dopamine in gastrointestinal disease.

Authors:  G B Glavin; S Szabo
Journal:  Dig Dis Sci       Date:  1990-09       Impact factor: 3.199

4.  Central and peripheral dopamine D1/DA1 receptor modulation of gastric secretion and experimental gastric mucosal injury.

Authors:  G B Glavin; A M Hall
Journal:  Gen Pharmacol       Date:  1995-10

5.  Epithelial cell proliferation in rat forestomach and glandular stomach mucosa induced by catechol and analogous dihydroxybenzenes.

Authors:  M A Shibata; M Hirose; M Yamada; M Tatematsu; S Uwagawa; N Ito
Journal:  Carcinogenesis       Date:  1990-06       Impact factor: 4.944

6.  Catecholamine-synthesizing enzymes in the rat stomach.

Authors:  N Bäck; M Ahonen; S Soinila; E Kivilaakso; T Kiviluoto
Journal:  Histochem Cell Biol       Date:  1995-07       Impact factor: 4.304

7.  Dopamine receptors in human gastrointestinal mucosa.

Authors:  D E Hernandez; G A Mason; C H Walker; J E Valenzuela
Journal:  Life Sci       Date:  1987-12-21       Impact factor: 5.037

8.  Pharmacological characterization of the D2 dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary.

Authors:  A Enjalbert; J Bockaert
Journal:  Mol Pharmacol       Date:  1983-05       Impact factor: 4.436

9.  Haloperidol and oestrogens induce c-myc and c-fos expression in the anterior pituitary gland of the rat.

Authors:  A C Cherñavsky; A V Valerani; J A Burdman
Journal:  Neurol Res       Date:  1993-10       Impact factor: 2.448

10.  Dopaminergic defect of enteric nervous system in Parkinson's disease patients with chronic constipation.

Authors:  C Singaram; W Ashraf; E A Gaumnitz; C Torbey; A Sengupta; R Pfeiffer; E M Quigley
Journal:  Lancet       Date:  1995-09-30       Impact factor: 79.321

View more
  13 in total

Review 1.  Emerging role of dopamine in neovascularization of pheochromocytoma and paraganglioma.

Authors:  Thamara E Osinga; Thera P Links; Robin P F Dullaart; Karel Pacak; Anouk N A van der Horst-Schrivers; Michiel N Kerstens; Ido P Kema
Journal:  FASEB J       Date:  2017-03-06       Impact factor: 5.191

2.  Biogenic amines serotonin and dopamine regulate cholangiocyte hyperplastic and neoplastic growth.

Authors:  Gabriel A Frampton; Huang Li; Jonathan Ramirez; Akimuddin Mohamad; Sharon Demorrow
Journal:  World J Gastrointest Pathophysiol       Date:  2010-06-15

3.  Aripiprazole an atypical antipsychotic protects against ethanol induced gastric ulcers in rats.

Authors:  Abdulrahman Al Asmari; Mohammed Arshaduddin; Ibrahim Elfaki; Saeed Kadasah; Abdulrahman Al Robayan; Saeed Al Asmary
Journal:  Int J Clin Exp Med       Date:  2014-08-15

4.  DRD2/DARPP-32 expression correlates with lymph node metastasis and tumor progression in patients with esophageal squamous cell carcinoma.

Authors:  Li Li; Masaki Miyamoto; Yuma Ebihara; Seiji Mega; Ryo Takahashi; Ryunosuke Hase; Hiroyuki Kaneko; Masatoshi Kadoya; Tomoo Itoh; Toshiaki Shichinohe; Satoshi Hirano; Satoshi Kondo
Journal:  World J Surg       Date:  2006-09       Impact factor: 3.352

Review 5.  Understanding the role of dopamine in cancer: past, present and future.

Authors:  Christopher E Grant; Amy L Flis; Bríd M Ryan
Journal:  Carcinogenesis       Date:  2022-06-27       Impact factor: 4.741

6.  Increased local dopamine secretion has growth-promoting effects in cholangiocarcinoma.

Authors:  Monique Coufal; Pietro Invernizzi; Eugenio Gaudio; Francesca Bernuzzi; Gabriel A Frampton; Paolo Onori; Antonio Franchitto; Guido Carpino; Jonathan C Ramirez; Domenico Alvaro; Marco Marzioni; Guido Battisti; Antonio Benedetti; Sharon DeMorrow
Journal:  Int J Cancer       Date:  2010-05-01       Impact factor: 7.396

7.  Dopamine D2 receptor polymorphisms and adenoma recurrence in the Polyp Prevention Trial.

Authors:  Gwen Murphy; Amanda J Cross; Leah S Sansbury; Andrew Bergen; Adeyinka O Laiyemo; Paul S Albert; Zhuoqiao Wang; Binbing Yu; Teresa Lehman; Aravind Kalidindi; Rama Modali; Arthur Schatzkin; Elaine Lanza
Journal:  Int J Cancer       Date:  2009-05-01       Impact factor: 7.396

8.  Transforming growth factor-beta1 (TGF-beta1) and acetylcholine (ACh) alter nitric oxide (NO) and interleukin-1beta (IL-1beta) secretion in human colon adenocarcinoma cells.

Authors:  Roman Paduch; Martyna Kandefer-Szerszeń
Journal:  In Vitro Cell Dev Biol Anim       Date:  2009-06-24       Impact factor: 2.416

Review 9.  Role of dopamine in malignant tumor growth.

Authors:  S Basu; P S Dasgupta
Journal:  Endocrine       Date:  2000-06       Impact factor: 3.925

10.  Epigenetic repression of the dopamine receptor D4 in pediatric tumors of the central nervous system.

Authors:  Rebekka Unland; Kornelius Kerl; Sabrina Schlosser; Nicole Farwick; Tanja Plagemann; Birigit Lechtape; Steven C Clifford; Jonas H Kreth; Joachim Gerss; Jörg Mühlisch; Günther H S Richter; Martin Hasselblatt; Michael C Frühwald
Journal:  J Neurooncol       Date:  2013-11-22       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.